tiprankstipranks
Trending News
More News >

Portfolio #1 - New Portfolio

Portfolio #1
Individual Investor
Ranked #350,023 out of 824,216 TipRanks' Investors
Success Rate
35%
198 out of 571
profitable transactions
Average Return
42.01%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 12.77%
6-Month Return▲ 95.32%
12-Month Return▲ 59.33%
YTD Return▲ 66.16%
Total Return▲ 353.34%

Best Trade

Opened at
Closed at-
Gain▲ 6951.74%

Bio

General portfolio. I have a private one which I am more active in

Performance

19.30%0-19.30%
▼ 6.38%
▼ 5.57%
▼ 9.16%
Mar 2025
▲ 0.80%
▼ 0.87%
▲ 6.37%
Apr 2025
▲ 11.63%
▲ 6.28%
▲ 4.90%
May 2025
▲ 9.25%
▲ 5.14%
▲ 6.06%
Jun 2025
▲ 7.60%
▲ 2.30%
▲ 11.89%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 19.30%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 7.91%
Sep 2025
▲ 4.43%
▲ 0.77%
▲ 9.34%
Oct 2025
TipRanks AverageS&P 500Investor Portfolio
▼ 6.38%▼ 5.57%▼ 9.16%
▲ 0.80%▼ 0.87%▲ 6.37%
▲ 11.63%▲ 6.28%▲ 4.90%
▲ 9.25%▲ 5.14%▲ 6.06%
▲ 7.60%▲ 2.30%▲ 11.89%
▲ 2.76%▲ 2.05%▲ 19.30%
▲ 12.88%▲ 3.56%▲ 7.91%
▲ 4.43%▲ 0.77%▲ 9.34%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Rezolute
0%
0.00%
1
Open
Oct 21, 2025
Humacyte
0%
0.00%
1
Open
Oct 19, 2025
Mereo Biopharma Group Plc
0%
0.00%
1
Open
Oct 19, 2025
Zevra Therapeutics
0%
▼ 88.21%
3
Open
Oct 18, 2025
Artiva Biotherapeutics, Inc.
0%
0.00%
1
Open
Oct 18, 2025
ImmunityBio
0%
0.00%
1
Open
Oct 18, 2025
Maze Therapeutics, Inc.
0%
0.00%
1
Open
Oct 18, 2025
Skye Bioscience
0%
0.00%
1
Open
Oct 18, 2025
Fulcrum Therapeutics
0%
0.00%
1
Open
Oct 18, 2025
Hepion Pharmaceuticals
0%
0.00%
1
Open
Oct 18, 2025
Alto Neuroscience, Inc.
0%
0.00%
1
Open
Oct 18, 2025
Acumen Pharmaceuticals
0%
▲ 4.43%
1
Open
Oct 17, 2025
Mitsubishi UFJ
0%
▲ 2.12%
1
Open
Oct 16, 2025
Adverum Biotechnologies
0%
▼ 2.19%
1
Open
Oct 16, 2025
Mawson Infrastructure Group
0%
▲ 68.17%
1
Open
Oct 14, 2025
Diginex Ltd.
0%
▼ 53.23%
1
Open
Oct 09, 2025
Allarity Therapeutics
0%
▼ 11.18%
1
Open
Oct 08, 2025
Denali Therapeutics
0%
▲ 13.49%
1
Open
Oct 02, 2025
Kymera Therapeutics
0%
▲ 8.04%
1
Open
Oct 02, 2025
OKYO Pharma Limited Sponsored ADR
0%
▲ 22.73%
1
Open
Oct 02, 2025